Avanos Medical (AVNS) EBIT (2016 - 2024)
Historic EBIT for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $12.0 million.
- Avanos Medical's EBIT rose 90000.0% to $12.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $33.5 million, marking a year-over-year increase of 24895.83%. This contributed to the annual value of $4.2 million for FY2023, which is 8816.9% down from last year.
- Per Avanos Medical's latest filing, its EBIT stood at $12.0 million for Q3 2024, which was up 90000.0% from $6.3 million recorded in Q2 2024.
- In the past 5 years, Avanos Medical's EBIT ranged from a high of $16.6 million in Q4 2022 and a low of -$47.2 million during Q4 2020
- Its 5-year average for EBIT is -$663157.9, with a median of $1.2 million in 2023.
- Within the past 5 years, the most significant YoY rise in Avanos Medical's EBIT was 350000.0% (2021), while the steepest drop was 216666.67% (2021).
- Over the past 5 years, Avanos Medical's EBIT (Quarter) stood at -$47.2 million in 2020, then skyrocketed by 52.54% to -$22.4 million in 2021, then soared by 174.11% to $16.6 million in 2022, then plummeted by 32.53% to $11.2 million in 2023, then grew by 7.14% to $12.0 million in 2024.
- Its last three reported values are $12.0 million in Q3 2024, $6.3 million for Q2 2024, and $4.0 million during Q1 2024.